HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Uchi Selected Research

Extramammary Paget Disease (Paget Disease, Extramammary)

6/2016Usefulness of docetaxel as first-line chemotherapy for metastatic extramammary Paget's disease.
5/2010Overexpression of stromal cathepsin K expression correlates with invasiveness of extramammary Paget's disease.
3/2010Gelatinases may play an important role in the progression of extramammary Paget's disease.
6/2008Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease.
3/2007Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease.
1/2007Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Uchi Research Topics

Disease

32Melanoma (Melanoma, Malignant)
10/2022 - 01/2006
31Neoplasms (Cancer)
10/2020 - 01/2006
15Atopic Dermatitis (Atopic Eczema)
06/2018 - 12/2003
9Inflammation (Inflammations)
02/2019 - 03/2002
9Yusho Disease
08/2015 - 04/2011
8Poisoning
02/2018 - 10/2008
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 11/2007
7Skin Diseases (Skin Disease)
01/2018 - 11/2007
6Neoplasm Metastasis (Metastasis)
01/2021 - 07/2013
6Extramammary Paget Disease (Paget Disease, Extramammary)
06/2016 - 01/2007
5Psoriasis (Pustulosis Palmaris et Plantaris)
02/2019 - 03/2006
5Disease Progression
10/2018 - 03/2006
5Wasting Syndrome (Wasting Disease)
05/2015 - 01/2012
5Carcinogenesis
12/2013 - 05/2005
4Hemangiosarcoma (Angiosarcoma)
01/2018 - 10/2007
3Skin Ulcer
12/2019 - 04/2015
3Wounds and Injuries (Trauma)
12/2019 - 10/2017
3Eczema
06/2018 - 03/2011
3Vitiligo
06/2017 - 01/2006
3Foodborne Diseases
10/2015 - 10/2009
2Basal Cell Carcinoma (Rodent Ulcer)
09/2022 - 11/2007
2Dermatitis
02/2019 - 06/2018
2Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2019 - 05/2017
2Necrosis
01/2018 - 05/2012
2Fever (Fevers)
01/2018 - 11/2014
2Edema (Dropsy)
08/2017 - 03/2002
2Acne Vulgaris
01/2017 - 04/2011
2Bowen's Disease (Disease, Bowen)
01/2017 - 11/2007
2Birth Weight (Birth Weights)
01/2015 - 01/2012
2Cough
11/2014 - 10/2008
2Lichen Planus (Lichen Ruber Planus)
03/2014 - 10/2009
2Carcinoma (Carcinomatosis)
07/2013 - 06/2013
2Fatigue
01/2011 - 10/2008
2Neurofibrosarcoma (MPNST)
09/2010 - 06/2010
2Arthralgia (Joint Pain)
05/2009 - 10/2008
2Contact Dermatitis (Eczema, Contact)
06/2003 - 03/2002
1Acute Generalized Exanthematous Pustulosis
01/2020
1Chloracne
07/2018

Drug/Important Bio-Agent (IBA)

18DioxinsIBA
07/2018 - 05/2009
17NivolumabIBA
05/2021 - 07/2016
10Polychlorinated Biphenyls (PCBs)IBA
02/2018 - 05/2008
9Proteins (Proteins, Gene)FDA Link
06/2018 - 03/2006
8Immune Checkpoint InhibitorsIBA
01/2021 - 05/2017
8Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
07/2018 - 01/2012
6AntibodiesIBA
08/2022 - 05/2005
6IpilimumabIBA
11/2020 - 01/2018
6Polychlorinated Dibenzodioxins (TCDD)IBA
02/2018 - 01/2012
5pembrolizumabIBA
01/2020 - 01/2017
5Biomarkers (Surrogate Marker)IBA
11/2019 - 05/2017
4Monoclonal AntibodiesIBA
10/2020 - 01/2017
4Cytochrome P-450 CYP1A1 (CYP1A1)IBA
07/2018 - 01/2012
4Immunoglobulin E (IgE)IBA
04/2011 - 09/2008
36-formylindolo(3,2-b)carbazoleIBA
02/2019 - 10/2017
3Programmed Cell Death 1 ReceptorIBA
01/2019 - 01/2018
3Filaggrin ProteinsIBA
06/2018 - 10/2014
3Biological ProductsIBA
06/2018 - 01/2015
3Rice Bran OilIBA
02/2018 - 10/2008
3Polychlorinated DibenzofuransIBA
02/2018 - 10/2008
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2017 - 05/2006
3CytokinesIBA
05/2017 - 01/2011
3Cathepsin KIBA
01/2011 - 05/2010
2dabrafenibIBA
12/2021 - 07/2018
2trametinibIBA
12/2021 - 07/2018
2Adrenocorticotropic Hormone (ACTH)FDA Link
01/2019 - 05/2017
2SteroidsIBA
01/2019 - 03/2006
2Ointments (Pastes)IBA
12/2018 - 06/2018
2cinnamaldehyde (cinnamic aldehyde)FDA Link
07/2018 - 01/2017
2LigandsIBA
06/2018 - 06/2017
2InterleukinsIBA
01/2018 - 03/2011
2Dacarbazine (DIC)FDA LinkGeneric
08/2017 - 07/2016
2InterferonsIBA
05/2017 - 03/2011
2dibenzofuranIBA
05/2015 - 04/2011
2S100 Proteins (S 100 Protein)IBA
12/2013 - 10/2008
2ChemokinesIBA
10/2013 - 09/2007
22,3,4,7,8-pentachlorodibenzofuranIBA
08/2013 - 10/2008
2Cadherins (E-Cadherin)IBA
07/2013 - 01/2007
2Interleukin-22 (IL-22)IBA
01/2011 - 01/2011
2Substance PIBA
01/2011 - 12/2010
2matrigelIBA
01/2011 - 12/2010
2p38 Mitogen-Activated Protein KinasesIBA
10/2009 - 03/2007
2NF-kappa B (NF-kB)IBA
10/2009 - 03/2007
2CholesterolIBA
05/2009 - 10/2008
2Cyclin D1IBA
10/2007 - 03/2007
2Tacrolimus (Prograf)FDA LinkGeneric
03/2006 - 07/2004
2CX 659SIBA
06/2003 - 03/2002
15-((glucopyranosyloxy)methyl)uracilIBA
09/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1indirubinIBA
12/2019
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2019
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2019
1GlucocorticoidsIBA
01/2019
1Pharmaceutical PreparationsIBA
12/2018
1LiraglutideFDA Link
12/2018
1Glucagon-Like Peptide-1 ReceptorIBA
12/2018
1Glucagon-Like Peptide 1 (GLP 1)IBA
12/2018
1keishibukuryoganIBA
07/2018

Therapy/Procedure

17Therapeutics
10/2022 - 07/2004
4Drug Therapy (Chemotherapy)
11/2020 - 06/2016
4Immunotherapy
11/2019 - 01/2018
2Kampo Medicine (Kampo)
07/2018 - 01/2011